About Us
BOCAIR is established as Australia and New Zealand’s exclusive manufacturer of BOCA Air Sanitiser products.
From the beginnings of the pandemic, we at BOCAIR recognised that we needed an absolute solution to help effectively eliminate the hundreds of harmful pathogens present in the air.
With the rise of numerous COVID-19 variants as well as the increased prevalence of seasonal viruses, health care professionals and Government bodies have acknowledged major concerns regarding the transmission of these airborne pathogens.
Extensive research and development led us to create the BOCA Air Sanitiser - a product which you can trust to cleanse the air you breathe and ensure that it is free from harmful pathogens. We at BOCAIR know the importance of feeling safe in your own home, which is why you can have faith that BOCA Air Sanitiser is the absolute solution.
BOCA™ Technology
Comprehensive research by a medical product development company was conducted prior to the development of BOCA Air Sanitiser to ensure accuracy and reliability. This product development company has produced up to 14 registered patents and several since have been granted.
Patents for the key technologies utilised during the in the air sanitiser process have been filed in Australia as Patent Pending.
The technology utilised in the development of BOCA Air Sanitiser involves a unique process that assists in deactivating harmful pathogens present around us, rendering them as inactive. This unique process is possible due to the scientific discoveries on electrolysis and ionisation of water molecules.
Our factory based in China is equipped with sixteen industrial-standard production lines, with a daily capacity of 8000 to 12000 units. The factory has two certifications from the International Organization for Standardization (ISO); the ISO 9001 and the ISO 14001.
During more than eight years’ development, the performance of our technology has been extensively tested and safety assured by a wide range of world-class independent laboratories.
The size of BOCA Air Sanitiser caters to both small and large spaces to best suit all customer preference and needs. Further, the product's free standing feature allows customers to utilise BOCA Air Sanitiser in various academic health, business and age-care settings.
News
November 2024:
We has been granted the first Australian patent (AU. 2022203990)
September 2023:
Testing was done at the Intertek Group laboratory, our product conducted an evaluation of 99.97% kill rate on Staphylococcus albus. Intertek Group plc is one of the world's leading groups specializing in analysis, control and certification of products and systems, with over 40,000 employees in 100 countries.
October 2022:
In Australia, Eurofins ams Laboratories Pty Ltd completed an Airborne Disinfection Efficacy Study, our device has shown virucidal efficacy against Murine hepatitis virus, by achieving average 97.18% kill rate, based on TGA requirement for on hard non-porous surfaces.
June 2022:
BOCA products have filed three patent applications in Australia for our exclusive technology.
February 2022:
The technology utilised in our BOCA products have been granted four international patents.
May 2021:
BOCA’s core device has been tested and certified by the CNAS TESTING. It has passed the disinfection effect test of eleven viruses and bacteria.
April 2021:
International GLP Safety Evaluation states that the active composite particle produced by this device is harmless to all organisms.
